Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Helus Pharma Inc. (HELP) Form 6-K — Oct 1, 2026

$HELPForm 6-KFiled Oct 1, 2026, 8:45 PM ET0001833141-26-000087Original filing

Helus Pharma Inc. completed its legal name change from Cybin Inc. effective October 1, 2026, following shareholder approval at the September 22, 2026 annual and special meeting. The change reflects the company's anticipated transformation from a clinical-stage developer to a commercial-ready pharmaceutical company.

Key figures

New isin
CA4234921076
New cusip
423492107
Name change effective
2026-10-01
Ticker symbol unchanged
HELP

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Helus Pharma Inc. (HELP) Form 6-K — Oct 1, 2026: AI Analysis | Signal8